Weekly Dose of Optimism #195
Eli Lilly has developed a promising gene therapy targeting LDL cholesterol, potentially preventing heart disease with a single infusion. The therapy has shown significant reductions in LDL cholesterol levels during early trials. This breakthrough could significantly impact global health, as high LDL cholesterol is linked to millions of deaths annually.
- ▪Eli Lilly's gene therapy targets PCSK9, responsible for LDL cholesterol, showing reductions of up to 62%.
- ▪High LDL cholesterol contributes to approximately 4.4 million deaths each year worldwide.
- ▪The therapy could provide long-term benefits with a single treatment, unlike current PCSK9 medications that require ongoing use.
Not Boring files mainly under business. We currently carry 7 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Not Boring |
| Canonical URL | https://www.notboring.co/p/weekly-dose-of-optimism-195 |
| Publication time | Fri, 29 May 2026 12:32:20 GMT |
| Retrieval time | 2026-05-29T12:40:00.348Z |
| Last seen | 2026-05-29T12:40:00.348Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | XsN7FSFVv8bL |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Weekly Dose of Optimism #195LDL Gene Therapy, GLP-1s slow Cancer, Supersonic Hermeus, Nanotech, Moon Base + Extra DosesMay 29, 2026∙ PaidShareHi friends 👋, Happy Friday, and welcome to our 195th Weekly Dose of Optimism.Man, just when I thought it was going to be hard to top last week’s Dose, we have an LDL cholesterol-fighting gene therapy, evidence that GLP-1s slow cancer, supersonic flight, and nanotech, and a Moon Base. We also have the coolest Science Breakthroughs roundup yet. Even a massive Blue Origin explosion can’t slow us down. If you get through this and want even more optimism injected into your veins, check out this week’s essay: Let’s get to it.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Not Boring.
